First Rib Resection Versus Avulsion for Thoracic Outlet Syndrome
Launched by UNIVERSITY OF SULAIMANI · Oct 17, 2023
Trial Information
Current as of November 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different surgical methods for treating thoracic outlet syndrome, a condition that can cause pain and discomfort due to pressure on the nerves and blood vessels in the neck and upper chest. The trial aims to compare the results of removing the first rib (a procedure called resection) with a technique called avulsion, where the rib is detached but not fully removed. Researchers believe that avulsion may lead to better recovery and less pain after surgery.
To participate in this trial, patients must have a specific type of thoracic outlet syndrome known as neurogenic thoracic outlet syndrome. Unfortunately, those with other types of the condition, such as vascular thoracic outlet syndrome, cannot join. Participants in the trial can expect to undergo one of the two surgical procedures and will be monitored closely afterward to see which method leads to better outcomes. The study is currently looking for volunteers of all ages and genders.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: any patient diagnosed as a case of neurogenic thoracic outlet syndrome -
- • Exclusion Criteria: patients with other types of thoracic outlet syndrome (vascular TOS)
- • -
About University Of Sulaimani
The University of Sulaimani is a leading academic institution in the Kurdistan Region of Iraq, dedicated to advancing education, research, and community health. With a strong emphasis on interdisciplinary collaboration, the university conducts innovative clinical trials aimed at improving healthcare outcomes and addressing regional health challenges. Its commitment to ethical research practices and adherence to international standards ensures that all clinical studies are conducted with the utmost integrity, contributing valuable insights to the global medical community. Through partnerships with local and international organizations, the University of Sulaimani strives to enhance medical knowledge and promote public health initiatives in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sulaymaniyah, Iraq
Patients applied
Trial Officials
fahmi Kakamad, PhD
Study Chair
University of Sulaimani
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported